Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 022065

Expand all

IXEMPRA KIT (IXABEPILONE)
15MG/VIAL Marketing Status: Prescription

Active Ingredient: IXABEPILONE
Proprietary Name: IXEMPRA KIT
Dosage Form; Route of Administration: INJECTABLE; IV (INFUSION)
Strength: 15MG/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N022065
Product Number: 001
Approval Date: Oct 16, 2007
Applicant Holder Full Name: R-PHARM US LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

IXEMPRA KIT (IXABEPILONE)
45MG/VIAL Marketing Status: Prescription

Active Ingredient: IXABEPILONE
Proprietary Name: IXEMPRA KIT
Dosage Form; Route of Administration: INJECTABLE; IV (INFUSION)
Strength: 45MG/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N022065
Product Number: 002
Approval Date: Oct 16, 2007
Applicant Holder Full Name: R-PHARM US LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English